Compare · RGC vs SNDL
RGC vs SNDL
Side-by-side comparison of Regencell Bioscience Holdings Limited (RGC) and SNDL Inc. (SNDL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RGC and SNDL operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $4.72B, about 15.9x SNDL ($297.8M).
- Over the past year, RGC is down 44.1% and SNDL is down 46.8% - RGC leads by 2.7 points.
- SNDL has been more active in the news (7 items in the past 4 weeks vs 1 for RGC).
- SNDL has more recent analyst coverage (4 ratings vs 0 for RGC).
PerformanceRGC-44.12%SNDL-46.82%
2025-10-20+0.00%2026-10-16
- Company
- Regencell Bioscience Holdings Limited
- SNDL Inc.
- Price
- $9.62+3.05%
- $1.25+3.29%
- Market cap
- $4.72B
- $297.8M
- 1M return
- +63.52%
- -8.06%
- 1Y return
- -44.12%
- -46.82%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2019
- News (4w)
- 1
- 7
- Recent ratings
- 0
- 4
SNDL
SNDL Inc.
Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Latest RGC
- SEC Form 20-F filed by Regencell Bioscience Holdings Limited
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
Latest SNDL
- SEC Form SC TO-C filed by SNDL Inc.
- SEC Form 6-K filed by SNDL Inc.
- SNDL Announces 2026 Annual and Special Shareholders Meeting Results, Select Preliminary Third Quarter Results and Capital Return Initiatives
- SEC Form 6-K filed by SNDL Inc.
- SNDL to Report Third Quarter 2026 Financial Results on October 27, 2026
- SEC Form 6-K filed by SNDL Inc.
- SNDL Announces Resignation of Director
- SEC Form 6-K filed by SNDL Inc.
- SEC Form 6-K filed by SNDL Inc.
- SNDL Announces Successful Completion of EU-GMP Audit at Atholville Facility